Signifier Raises $35M to Accelerate Commercialization of eXciteOSA Therapy

Proceeds of the financing will be directed towards commercialization of eXciteOSA in core target markets, continued development of proprietary digital patient and physician interface platforms, the generation of additional clinical data to reinforce the therapeutic efficacy of eXciteOSA, and progressing reimbursement.

Leave a Reply